Indeed, many factors other than the primary neurological disease, including age, BMI, cardiovascular risk factors, unrecognized head injury, etc., may be confounding factors that influence blood NfL and should therefore be taken into account when evaluating this biomarker in patients. The gene discussed is NEFL; the disease is nervous system disorder.